Chargement en cours...
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
BACKGROUND: Aspirin and heparin are widely used as preventive strategy to reduce the high risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL). This review supersedes a previous, out‐of‐date review that evaluated all potential therapies for preventing recurrent pregnancy...
Enregistré dans:
| Publié dans: | Cochrane Database Syst Rev |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
2020
|
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7195627/ https://ncbi.nlm.nih.gov/pubmed/32358837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012852.pub2 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|